WeVote

Bill

Bill

A 5409

Requires local social services districts distribute shelter information specifically for lesbian, gay, bisexual, transgender, and gender non-conforming persons

2025 Regular Session Introduced by Steven Raga

Inpatient LAI antipsychotics reimbursed separately from DRG, at the same NJ FamilyCare outpatient rate for the drug, improving payment accuracy and access.

REFERRED TO SOCIAL SERVICES
0
WeVote Research Nonpartisan
Bill Summary · A 5409

Bill A 5409 – Summary

Note: The bill’s title references distributing shelter information for LGBTQ+ persons, but the introduced text of the bill concerns NJ FamilyCare reimbursement for long-acting injectable antipsychotic drugs. The introduced provisions below reflect the content as filed.

Overview

  • Purpose: Reform NJ FamilyCare inpatient reimbursement for long-acting injectable (LAI) antipsychotic drugs to better reflect drug costs and promote access, potentially improving outcomes and reducing hospital readmissions.
  • Status: Referred to Social Services (introduced March 6, 2025; Assembly). There is a companion consideration in the Senate (S 3837, S 5925).
  • Geographic scope: New Jersey; affects NJ FamilyCare (Medicaid/CHIP program).

Key Provisions

1) Inpatient reimbursement for LAI antipsychotic drugs
- Inpatient LAI drug reimbursement shall be:
- Separate and distinct from any inpatient DRG (Diagnostic Related Group) reimbursement payment.
- Set at a rate equal to the NJ FamilyCare outpatient reimbursement for the identical LAI drug.
- Effect: The cost of the LAI drug itself will be reflected in inpatient payments, rather than being wrapped into a DRG payment that often underestimates drug costs.

2) Coverage not altered
- The act shall not change existing coverage requirements for LAI antipsychotic drugs when administered in an inpatient setting.

3) Definitions
- DRG reimbursement system: Inpatient payment model classifying patients for reimbursement purposes.
- Long-acting injectable antipsychotic drugs: FDA-approved medications that treat symptoms of major psychiatric disorders (e.g., schizophrenia, bipolar disorder) for up to 24 weeks with a single dose.
- NJ FamilyCare: The Medicaid program and Children’s Health Insurance Program in New Jersey.

4) Administrative actions
- The Commissioner of Human Services must:
- Apply for necessary State plan amendments or waivers to implement the bill and secure federal financial participation for Medicaid expenditures.
- Adopt rules and regulations to implement the act under the Administrative Procedure Act.

5) Effective date
- The act takes effect on the first day of the fourth month after enactment.
- The Commissioner may begin anticipatory administrative action before that date to implement the act.

Impact and Implications

  • For patients: Potentially improved access to LAI antipsychotic medications in inpatient settings due to reimbursement reflecting drug costs.
  • For providers: Inpatient hospitals and other inpatient facilities may receive reimbursement that aligns more closely with drug acquisition costs, possibly influencing formulary and prescribing practices.
  • For state finances: Requires state plan amendments and possible federal funding adjustments; administrative rulemaking will govern implementation.
  • Overall goal: Enhance continuity of care for individuals with serious mental illness by ensuring inpatient reimbursement more accurately accounts for expensive LAI therapies, with the expectation of better clinical outcomes and fewer readmissions.

Procedural Details

  • Legislative actions:
    • Assembly introduction: March 6, 2025; referred to Assembly Aging and Human Services Committee.
    • Cross-reference: Referred to Social Services (February 13, 2025) in related actions.
  • Related measures: Companion bills in the Senate (S 3837, S 5925).

If you’d like, I can provide a side-by-side comparison with current NJ FamilyCare DRG reimbursement practices to illustrate the financial impact more concretely.

Compiled from official sources — confirm details with the bill’s official record.

Sign in to ask a question.